Quality assurance for bone densitometry research studies: Concept and impact
Tóm tắt
A concept for quality assurance (QA) in bone densitometry has been developed for clinical multicenter studies. Major elements provided by a coordinating center comprise (1) consulting services and certification of participating centers in the start-up phase of the study, (2) review of scan data acquired on QA standards for cross-calibration and longitudinal assessment of scanner stability, (3) review of selected patient data as well as of problem cases during the study, and (4) comprehensive review and correction of patient results based on QA data after conclusion of the study. Limitations of phantom-based QA data should be acknowledged. Typical problems encountered during research studies and guidelines for solutions are presented. Successful implementation of QA measures may yield substantial enhancement of statistical power. Depending on the study design and the variability of response within patient groups, improvement in precision due to QA measures may reduce the smallest detectable difference between subject groups or, alternatively, sample size by a few to more than 50%, and thus may contribute to a substantial reduction in study cost. Formulae for calculation of the magnitude of these effects are presented. To maximize the net benefit, QA efforts have to be limited to levels that assure reliability of the data at acceptable QA cost. While QA programs at individual clinical sites or for local practitioners may not need to be as extensive as for multicenter clinical trials, awareness of the potential problems and implementation of basic QA measures will help in obtaining high-quality bone densitometry results.
Tài liệu tham khảo
Burkhart RL. Quality assurance programs for diagnostic radiology facilities. FDA, 1980.
Accreditation manual for hospitals. Joint Commission on Accreditation of Healthcare Organizations, 1988.
ACR quality assurance guide. American College of Radiology, 1983.
Orwoll ES, Oviat SK. Longitudinal precision of dual-energy X-ray absorptiometry in a multicenter study. J Bone Miner Res 1991;6:191–7.
Kalender WA. A phantom for standardization and quality control in spinal bone mineral measurements by QCT and DXA: design considerations and specifications. Med Phys 1992;19:583–6.
Ramp WK, Yancey JM.P values and their problems. Bone Miner 1991;13:163–5.
Schlesselman JJ. Planning a longitudinal study.II. Frequency of measurement and study duration. J Chronic Dis 1973;26:561–70.
Lefante JJ. The power to detect differences in average rates of change in longitudinal studies. Stat Med 1990;9:437–46.
Genant HK, Faulkner KG, Glüer CC. Measurement of bone mineral density: current status. Am J Med 1991;91 Suppl 5B:49–53.
Wahner HW. Measurements of bone mass and bone density. Endocrinol Clin North Am 1989;18:995–1012.
Lang P, Steiger P, Faulkner KG, Glüer CC, Genant HK. Osteoporosis: current techniques and recent developments in quantitative bone densitometry. Radio Clin North Am 1991;29:49–76.
Mazess RB. Bone densitometry of the axial skeleton. Orthop Clin North Am 1990;21:51–63.
Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med 1987;106:40–5.
Riis BJ, Thomsen K, Strøm V, Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 1987;156:61–5.
Overgaard K, Riis BJ, Christiansen C, Pødenphant J, Johansen JS. Nasal calcitonin for treatment of established osteoporosis. Clin Edocrinol 1989;30:435–42.
Storm T, Thamsborg G, Steiniche T, Genant HK, Sørenson OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990;322:1265–71.
Watts NB, Harris ST, Genant HK, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990;323:73–9.
Fromm GA, Vega E, Plantalech L, Galich AM, Mautalen CA. Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis. Osteoporosis Int 1991;1:129–33.
Estilo MJ, Glüer CC, Faulkner KG, et al. Long-term precision and longitudinal sensitivity in vivo of quantitative computed tomography and dual X-ray aborptiometry. J Bone Miner Res 1991;6:335.
Kelly T, Slovick D, Schoenfield D, Neer R. Quantitative digital radiography versus dual photon absorptiometry of the lumbar spine. J Clin Endorcrinol Metab 1988;67:839–44.
Faulkner K, Glüer CC, Genant H. Characterization of DXA measurements in a multi-center clinical drug trial. Eur Radio 1991;l(Suppl):S126.
Gundry CR, Miller CW, Ramos E, et al. Dual-energy radiographic absorptiometry of the lumbar spine: clinical experience with two different systems. Radiology 1990;174:539–41.
Glüer CC, Faulkner KG, Powell MR, Genant HK. Accuracy of two different dual-energy X-ray absorptiometry systems: assessment of potential error sources. Radiology 1990;177(P):316.